Nikita Arumalla
Overview
Explore the profile of Nikita Arumalla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
65
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Z, Alveyn E, Dey M, Arumalla N, Russell M, Norton S, et al.
BMJ Open
. 2024 Nov;
14(11):e083620.
PMID: 39488428
Objective: Performance visualisation tools are increasingly being applied in healthcare to enhance decision-making and improve quality of care. However, there is a lack of comprehensive synthesis of their overall effectiveness...
2.
Yang Z, Arumalla N, Alveyn E, Gallagher S, Price E, Russell M, et al.
Rheumatol Adv Pract
. 2024 May;
8(2):rkae053.
PMID: 38765191
Objectives: To evaluate trust-level performance in time to initiation of DMARD therapy in patients with early inflammatory arthritis (EIA), with identification of the change in performance trajectories over time and...
3.
Watson K, Sheldon H, Pallari E, Arumalla N, Olive R, Boiko O, et al.
Rheumatology (Oxford)
. 2024 Feb;
63(10):2721-2733.
PMID: 38402509
Objectives: This study evaluated the scale-up of a remote monitoring service, capturing monthly Rheumatoid Arthritis Impact of Disease scores and patient-generated text messages, for patients with rheumatoid arthritis (RA; in...
4.
Arumalla N, Chan C, Gibson M, Man Y, Adas M, Norton S, et al.
Arthritis Rheumatol
. 2023 May;
75(11):1892-1903.
PMID: 37204273
Objective: The inflammatory arthritides (IAs) make up a significant proportion of conditions followed up in rheumatology clinics. These patients require regular monitoring, but this is increasingly difficult with rising patient...
5.
Rutter-Locher Z, Arumalla N, Norton S, Taams L, Kirkham B, Bannister K
Semin Arthritis Rheum
. 2023 May;
61:152207.
PMID: 37163841
Background: Targeted pain relief is a major unmet medical need for patients with inflammatory arthritis (IA), where approximately 40% of patients experience persistent pain. Self-reported questionnaires which report on pain...
6.
Woznitza N, Ghimire B, Devaraj A, Janes S, Piper K, Rowe S, et al.
Thorax
. 2022 Nov;
78(9):890-894.
PMID: 36351688
Method: People referred for CXR from primary care to a single acute district general hospital in London attended sessions that were prerandomised to either immediate radiographer (IR) reporting or standard...
7.
Subesinghe M, Bhuva S, Arumalla N, Cope A, DCruz D, Subesinghe S
Rheumatology (Oxford)
. 2021 Aug;
61(5):1769-1782.
PMID: 34463703
2-deoxy-2[18F]fluoro-D-glucose (FDG) PET-CT has revolutionized oncological imaging. The cellular processes that make cancer cells visible on FDG PET-CT also occur in a number of inflammatory cells. Exploiting this phenomenon has...
8.
Yaseen B, Lopez H, Taki Z, Zafar S, Rosario H, Ahmed Abdi B, et al.
Rheumatology (Oxford)
. 2020 May;
59(9):2625-2636.
PMID: 32365362
Objectives: Cytokines released by infiltrating T cells may promote mechanisms leading to fibrosis in scleroderma. The aim of this study was to investigate the role of the Th2 cytokine IL-31,...
9.
Taki Z, Gostjeva E, Thilly W, Yaseen B, Lopez H, Mirza M, et al.
Arthritis Rheumatol
. 2020 Apr;
72(8):1361-1374.
PMID: 32237059
Objective: In systemic sclerosis (SSc), a persistent tissue repair process leads to progressive fibrosis of the skin and internal organs. The role of mesenchymal stem cells (MSCs), which characteristically initiate...
10.
Arumalla N, Coakley G
Lancet Infect Dis
. 2019 Dec;
20(3):266-267.
PMID: 31862241
No abstract available.